Interferon alfa-n3
| |
| Klinički podaci | |
|---|---|
| Robne marke | Alferon (Interferon Sciences Inc.), Alferon LDO, Alferon N Injection |
| AHFS/Drugs.com | alpha-n3.html Monografija |
| Identifikatori | |
| ATC kod | nije dodeljen |
| DrugBank | DB00018 |
| Hemijski podaci | |
| Formula | ? |
| Mol. masa | 0,000 |
| Fizički podaci | |
| Tačka topljenja | 61 °C (142 °F) |
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
Interferon alfa-n3 (Alferon-N) je lek koji se sastoji od prečišćenog prirodnog ljudskog interferon alfa proteina koji se koristi za lečenje genitalnih bradavica.[1][2][3]
- ↑ Sturgill MG, Rashidbaigi A, Liao MJ, Zhao XX, Hua J, Trout R, Knill JR, Grasing KW: Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity. J Clin Pharmacol. 2000 Jun;40(6):606-15. PMID 10868311
- ↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
- ↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.
- Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
- Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.
